Retatrutide Vs Ozempic: Next-generation Jab Doubles Weight Loss In Trial
Ozempic may have a stronger rival. An experimental weekly injection – Eli Lilly’s “retatrutide" – may be the most potent weight-loss drug yet. In a new trial, it helped people…
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 31 03:20 ETSource: News18
From the source
Read at news18.comRetatrutide Vs Ozempic: Next-generation Jab Doubles Weight Loss In Trial
Ozempic may have a stronger rival. An experimental weekly injection – Eli Lilly’s “retatrutide" – may be the most potent weight-loss drug yet. In a new trial, it helped people with type 2 diabetes lose an average of 20 kg, more than double the loss with Ozempic.
